missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30171373

CXCR1/IL-8RA Antibody (1122A) [Janelia Fluor™ 669], Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals FAB8628JF669

4522.00 NOK valid until 2025-12-16
Use promo code "24090" to get your promotional price.

Product Code. 30171373

  • 5670.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CXCR1/IL-8RA Monoclonal antibody specifically detects CXCR1/IL-8RA in Mouse samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CXCR1/IL-8RA
Monoclonal
Janelia Fluor 669
CD128, CD181, CD181 antigen, CDw128aC-C, chemokine (C-X-C motif) receptor 1, CKR-1, CMKAR1, C-X-C chemokine receptor type 1, CXC-R1, CXCR-1, High affinity interleukin-8 receptor A, IL-8 receptor type 1, IL-8R A, IL8R1, IL8RAC-C-CKR-1, IL8RBA, interleukin 8 receptor, alpha, interleukin-8 receptor type 1, interleukin-8 receptor type A
Mouse CXCR1/IL-8 RA Peptide, Accession # Q810W6
RUO
Primary
Mouse
Liquid
Flow Cytometry
1122A
50mM Sodium Borate
Rabbit
0.1 mL
Chemokines and Cytokines, Cytokine Research, GPCR, Immunology, Innate Immunity, Signal Transduction
3577
Store at 4°C in the dark.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.